Literature DB >> 20425900

Intervention: More MACE with zotarolimus-eluting stents than with sirolimus-eluting stents.

Bryony M Mearns.   

Abstract

Entities:  

Year:  2010        PMID: 20425900     DOI: 10.1038/nrcardio.2010.46

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

Authors:  Klaus Rasmussen; Michael Maeng; Anne Kaltoft; Per Thayssen; Henning Kelbaek; Hans Henrik Tilsted; Ulrik Abildgaard; Evald Høj Christiansen; Thomas Engstrøm; Lars Romer Krusell; Jan Ravkilde; Peter Riis Hansen; Knud Nørregaard Hansen; Steen Zabell Abildstrøm; Jens Aarøe; Jan Skov Jensen; Steen Dalby Kristensen; Hans Erik Bøtker; Morten Madsen; Søren Paaske Johnsen; Lisette Okkels Jensen; Henrik Toft Sørensen; Leif Thuesen; Jens Flensted Lassen
Journal:  Lancet       Date:  2010-03-16       Impact factor: 79.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.